Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

993 Optimizing management of immune checkpoint inhibitor-mediated toxicity in cancer patients

7 affiliations
  1. 12The Royal London Children’s Hospital and Queen Mary University of London
  2. 2Institute of Health System Science Northwell Health, Manhasset, NY, USA
  3. 3Internal Medicine, Northwell Health, Manhasset, New York, USA
  4. 4Northwell Northern Westchester Hospital, Mount Kisco, NY, USA
  5. 5Northwell Health LIJ Forest Hills, Forest Hills, NY, USA
  6. 6Zucker School of Medicine at Hofstra Northwell NS/LIJ, Manhasset, NY, USA
  7. 7Northwell Cancer Institute, Northwell Health, New Hyde Park, NY, USA

Related

  1. First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis
    Yinghong Wang, Christopher Fan, Krishnavathana Varatharajalu +29
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  2. Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
    Shreya Shambhavi, Aksa Alina Joy, Emilia Wilk +1
    Journal of medical casesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Advanced Therapies for the Management of Immune Checkpoint Inhibitor-Induced Colitis
    Cosimo Simone Matichecchia, Fabrizio Fanizzi, Alessandra Zilli +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath
    Tyler T Morad, Mohammad Keykhaei, Devon A Terraciano +3
    JACC: CardioOncologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  5. Corticosteroid-refractory checkpoint inhibitor pneumonitis in lung cancer: biological heterogeneity and mechanism-informed management
    Rong Zhang, Xiaoxue Zhang, Xiulan He +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0OncologyCrossref
BibTeX
@article{shah2026optimizing,
  title = {{993 Optimizing management of immune checkpoint inhibitor-mediated toxicity in cancer patients}},
  author = {Pratik Shah and Mark Butler and Neha Puttagunta and Michael Barsoum and Arsalan Boodhun and Roshni Saxena and Kit Cheng and Shuchismita Satpathy},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0993},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0993},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 993 Optimizing management of immune checkpoint inhibitor-mediated toxicity in cancer patients
AU  - Pratik Shah
AU  - Mark Butler
AU  - Neha Puttagunta
AU  - Michael Barsoum
AU  - Arsalan Boodhun
AU  - Roshni Saxena
AU  - Kit Cheng
AU  - Shuchismita Satpathy
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0993
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0993
SN  - 2051-1426
ER  -